Home > Balance Sheet > GLAND PHARMA
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹151 Cr₹238 Cr₹177 Cr₹181 Cr₹338 Cr

What is the latest Capital Work in Progress ratio of GLAND PHARMA ?

The latest Capital Work in Progress ratio of GLAND PHARMA is ₹151 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹151 Cr
Mar2024₹238 Cr
Mar2023₹177 Cr
Mar2022₹181 Cr
Mar2021₹338 Cr

How is Capital Work in Progress of GLAND PHARMA Trending?

Years Capital Work in Progress % Change
Mar2025 ₹151 Cr
-36.71
Mar2024 ₹238 Cr
34.23
Mar2023 ₹177 Cr
-1.95
Mar2022 ₹181 Cr
-46.49
Mar2021 ₹338 Cr -

Compare Capital Work in Progress of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹29,224.0 Cr -0.5% 10% 18.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,997.0 Cr 4.1% -1.3% -7.3% Stock Analytics
DIVIS LABORATORIES ₹171,900.0 Cr 3% 7.7% 7.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,804.0 Cr 2.1% 0.1% 26.8% Stock Analytics
DR REDDYS LABORATORIES ₹111,389.0 Cr 9.3% 6.6% 12% Stock Analytics
CIPLA ₹106,397.0 Cr 6.8% 7.7% -15.3% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-0.5%

10%

18.2%

SENSEX

-1.6%

3.7%

-2.7%


You may also like the below Video Courses